Regression From Prediabetes to Normal Glucose Regulation and Prevalence of Microvascular Disease in the Diabetes Prevention Program Outcomes Study (DPPOS) - PubMed (original) (raw)

Observational Study

. 2019 Sep;42(9):1809-1815.

doi: 10.2337/dc19-0244. Epub 2019 Jul 18.

Qing Pan 2, Emily B Schroeder 1 3, Rita R Kalyani 4, George A Bray 5, Samuel Dagogo-Jack 6, Neil H White 7, Ronald B Goldberg 8, Steven E Kahn 9, William C Knowler 10, Nestoras Mathioudakis 4, Dana Dabelea; Diabetes Prevention Program Research Group

Collaborators, Affiliations

Observational Study

Regression From Prediabetes to Normal Glucose Regulation and Prevalence of Microvascular Disease in the Diabetes Prevention Program Outcomes Study (DPPOS)

Leigh Perreault et al. Diabetes Care. 2019 Sep.

Abstract

Objective: Regression from prediabetes to normal glucose regulation (NGR) was associated with reduced incidence of diabetes by 56% over 10 years in participants in the Diabetes Prevention Program Outcomes Study (DPPOS). In an observational analysis, we examined whether regression to NGR also reduced risk for microvascular disease (MVD).

Research design and methods: Generalized estimating equations were used to examine the prevalence of aggregate MVD at DPPOS year 11 in people who regressed to NGR at least once (vs. never) during the Diabetes Prevention Program (DPP). Logistic regression assessed the relationship of NGR with retinopathy, nephropathy, and neuropathy, individually. Generalized additive models fit smoothing splines to describe the relationship between average A1C during follow-up and MVD (and its subtypes) at the end of follow-up.

Results: Regression to NGR was associated with lower prevalence of aggregate MVD in models adjusted for age, sex, race/ethnicity, baseline A1C, and treatment arm (odds ratio [OR] 0.78, 95% CI 0.65-0.78, P = 0.011). However, this association was lost in models that included average A1C during follow-up (OR 0.95, 95% CI 0.78-1.16, P = 0.63) or diabetes status at the end of follow-up (OR 0.92, 95% CI 0.75-1.12, P = 0.40). Similar results were observed in examination of the association between regression to NGR and prevalence of nephropathy and retinopathy, individually. Risk for aggregate MVD, nephropathy, and retinopathy increased across the A1C range.

Conclusions: Regression to NGR is associated with a lower prevalence of aggregate MVD, nephropathy, and retinopathy, primarily due to lower glycemic exposure over time. Differential risk for the MVD subtypes begins in the prediabetes A1C range.

Trial registration: ClinicalTrials.gov NCT00004992 NCT00038727.

© 2019 by the American Diabetes Association.

PubMed Disclaimer

Figures

Figure 1

Figure 1

Predicted, unadjusted prevalence of aggregate MVD (retinopathy, nephropathy, and/or neuropathy) (A), nephropathy (B), retinopathy (C), and neuropathy (D) as a function of A1C levels during DPPOS follow-up. Solid lines represent a smoothed, fitted relationship, whereas the dotted lines represent the pointwise 95% CI.

Figure 2

Figure 2

A1C over DPP and DPPOS for participants who ever versus never regressed from prediabetes to normoglycemia (includes those who have and have not developed diabetes). BAS, baseline.

Similar articles

Cited by

References

    1. Diabetes Prevention Program Research Group Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. Lancet Diabetes Endocrinol 2015;3:866–875 - PMC - PubMed
    1. Goldberg RB, Aroda VR, Bluemke DA, et al. .; Diabetes Prevention Program Research Group . Effect of long-term metformin and lifestyle in the Diabetes Prevention Program and its outcome study on coronary artery calcium. Circulation 2017;136:52–64 - PMC - PubMed
    1. Perreault L, Pan Q, Mather KJ, Watson KE, Hamman RF, Kahn SE; Diabetes Prevention Program Research Group . Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study. Lancet 2012;379:2243–2251 - PMC - PubMed
    1. Perreault L, Temprosa M, Mather KJ, et al. .; Diabetes Prevention Program Research Group . Regression from prediabetes to normal glucose regulation is associated with reduction in cardiovascular risk: results from the Diabetes Prevention Program Outcomes Study. Diabetes Care 2014;37:2622–2631 - PMC - PubMed
    1. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2004;27(Suppl. 1):S5–S10 - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources